Asset Advisors Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Sell
36,467
-201
-0.5% -$68.8K 1.21% 25
2026
Q1
$12.9M Buy
36,668
+1,154
+3% +$411K 1.23% 26
2025
Q4
$11.6M Buy
35,514
+380
+1% +$121K 1.07% 30
2025
Q3
$9.91M Buy
35,134
+547
+2% +$159K 0.94% 36
2025
Q2
$9.66M Sell
34,587
-14
-0% -$3.97K 0.95% 31
2025
Q1
$10.8M Sell
34,601
-516
-1% -$152K 1.13% 28
2024
Q4
$9.15M Sell
35,117
-817
-2% -$242K 0.96% 32
2024
Q3
$11.6M Buy
35,934
+2,954
+9% +$966K 1.2% 26
2024
Q2
$10.3M Buy
32,980
+829
+3% +$244K 1.12% 28
2024
Q1
$9.14M Buy
32,151
+390
+1% +$114K 1.02% 29
2023
Q4
$9.15M Buy
31,761
+833
+3% +$227K 1.12% 27
2023
Q3
$8.31M Sell
30,928
-178
-0.6% -$44.4K 1.12% 26
2023
Q2
$6.91M Sell
31,106
-1,550
-5% -$360K 0.88% 31
2023
Q1
$7.89M Sell
32,656
-2,647
-7% -$650K 1.03% 28
2022
Q4
$9.27M Buy
35,303
+1,535
+5% +$411K 1.22% 26
2022
Q3
$7.61M Buy
33,768
+2,235
+7% +$542K 1.08% 28
2022
Q2
$7.67M Buy
31,533
+840
+3% +$206K 1.05% 28
2022
Q1
$7.42M Buy
30,693
+15,111
+97% +$3.47M 0.83% 33
2021
Q4
$3.5M Buy
15,582
+210
+1% +$44.3K 0.35% 51
2021
Q3
$3.27M Sell
15,372
-19,804
-56% -$4.56M 0.36% 52
2021
Q2
$8.57M Buy
35,176
+227
+0.6% +$55.8K 0.95% 34
2021
Q1
$8.7M Buy
34,949
+2,745
+9% +$655K 1.02% 33
2020
Q4
$7.4M Buy
32,204
+1,093
+4% +$252K 0.96% 35
2020
Q3
$7.91M Sell
31,111
-965
-3% -$239K 1.19% 31
2020
Q2
$7.57M Sell
32,076
-1,391
-4% -$317K 1.21% 30
2020
Q1
$6.79M Buy
33,467
+20
+0.1% +$4.37K 1.26% 29
2019
Q4
$8.03M Buy
33,447
+365
+1% +$80.5K 1.17% 30
2019
Q3
$6.4M Buy
33,082
+5,595
+20% +$1.07M 1.02% 33
2019
Q2
$5.07M Buy
27,487
+1,295
+5% +$232K 0.85% 36
2019
Q1
$4.98M Buy
26,192
+161
+0.6% +$30.7K 0.89% 35
2018
Q4
$5.07M Sell
26,031
-1,620
-6% -$316K 1% 34
2018
Q3
$5.73M Buy
+27,651
New +$5.45M 0.95% 34

Other funds holding AMGN

Asset Advisors Investment Management's AMGN Position: Q2 2026 in Review

Asset Advisors Investment Management reduced its Amgen (AMGN) stake by 0.55% in Q2 2026, selling an estimated $68.8K and leaving 36,467 shares worth $13.2M. The position accounts for 1.21% of the portfolio, ranked #25.

Asset Advisors Investment Management first reported a position in AMGN in Q3 2018 and has held it in 32 quarters since. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Asset Advisors Investment Management held 36,467 shares of Amgen worth $13.2M as of Q2 2026.
  • Asset Advisors Investment Management sold 201 Amgen shares in Q2 2026, an estimated $68.8K.
  • Amgen made up 1.21% of Asset Advisors Investment Management's portfolio in Q2 2026, its #25 holding.
  • Asset Advisors Investment Management first reported a position in Amgen in Q3 2018 and has held it in 32 quarters since.
  • 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Asset Advisors Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.